CDKN2A and glioblastoma: Its result, along with the analysis of chromosomal copy number variations (CNVs), confirmed the diagnosis of anaplastic PXA: a methylation class characteristic for this tumor type was identified, along with a homozygous deletion of CDKN2A and the absence of other CNV signatures typical of glioblastoma.